Global Alpha- Antitrypsin Deficiency Treatment Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Alpha- Antitrypsin Deficiency Treatment Market Size 2017-2028

2.1.2 Alpha- Antitrypsin Deficiency Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Alpha- Antitrypsin Deficiency Treatment Segment by Type

2.2.1 CT-2009

2.2.2 POL-6014

2.2.3 ARO-AAT

2.2.4 ALNAAT-02

2.2.5 Others

2.3 Alpha- Antitrypsin Deficiency Treatment Market Size by Type

2.3.1 Alpha- Antitrypsin Deficiency Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2022)

2.4 Alpha- Antitrypsin Deficiency Treatment Segment by Application

2.4.1 Clinic

2.4.2 Hospital

2.4.3 Others

2.5 Alpha- Antitrypsin Deficiency Treatment Market Size by Application

2.5.1 Alpha- Antitrypsin Deficiency Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2022)

3 Alpha- Antitrypsin Deficiency Treatment Market Size by Player

3.1 Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Players

3.1.1 Global Alpha- Antitrypsin Deficiency Treatment Revenue by Players (2020-2022)

3.1.2 Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Players (2020-2022)

3.2 Global Alpha- Antitrypsin Deficiency Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Alpha- Antitrypsin Deficiency Treatment by Regions

4.1 Alpha- Antitrypsin Deficiency Treatment Market Size by Regions (2017-2022)

4.2 Americas Alpha- Antitrypsin Deficiency Treatment Market Size Growth (2017-2022)

4.3 APAC Alpha- Antitrypsin Deficiency Treatment Market Size Growth (2017-2022)

4.4 Europe Alpha- Antitrypsin Deficiency Treatment Market Size Growth (2017-2022)

4.5 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size Growth (2017-2022)

5 Americas

5.1 Americas Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022)

5.2 Americas Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)

5.3 Americas Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2017-2022)

6.2 APAC Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)

6.3 APAC Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Alpha- Antitrypsin Deficiency Treatment by Country (2017-2022)

7.2 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)

7.3 Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment by Region (2017-2022)

8.2 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022)

8.3 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.1 Global Alpha- Antitrypsin Deficiency Treatment Forecast by Regions (2023-2028)

10.1.1 Global Alpha- Antitrypsin Deficiency Treatment Forecast by Regions (2023-2028)

10.1.2 Americas Alpha- Antitrypsin Deficiency Treatment Forecast

10.1.3 APAC Alpha- Antitrypsin Deficiency Treatment Forecast

10.1.4 Europe Alpha- Antitrypsin Deficiency Treatment Forecast

10.1.5 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Forecast

10.2 Americas Alpha- Antitrypsin Deficiency Treatment Forecast by Country (2023-2028)

10.2.1 United States Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.2.2 Canada Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.2.3 Mexico Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.2.4 Brazil Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.3 APAC Alpha- Antitrypsin Deficiency Treatment Forecast by Region (2023-2028)

10.3.1 China Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.3.2 Japan Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.3.3 Korea Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.3.4 Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.3.5 India Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.3.6 Australia Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.4 Europe Alpha- Antitrypsin Deficiency Treatment Forecast by Country (2023-2028)

10.4.1 Germany Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.4.2 France Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.4.3 UK Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.4.4 Italy Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.4.5 Russia Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.5 Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Forecast by Region (2023-2028)

10.5.1 Egypt Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.5.2 South Africa Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.5.3 Israel Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.5.4 Turkey Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.5.5 GCC Countries Alpha- Antitrypsin Deficiency Treatment Market Forecast

10.6 Global Alpha- Antitrypsin Deficiency Treatment Forecast by Type (2023-2028)

10.7 Global Alpha- Antitrypsin Deficiency Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Adverum Biotechnologies, Inc.

11.1.1 Adverum Biotechnologies, Inc. Company Information

11.1.2 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.1.3 Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Adverum Biotechnologies, Inc. Main Business Overview

11.1.5 Adverum Biotechnologies, Inc. Latest Developments

11.2 Alnylam Pharmaceuticals, Inc.

11.2.1 Alnylam Pharmaceuticals, Inc. Company Information

11.2.2 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.2.3 Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Alnylam Pharmaceuticals, Inc. Main Business Overview

11.2.5 Alnylam Pharmaceuticals, Inc. Latest Developments

11.3 Applied Genetic Technologies Corporation

11.3.1 Applied Genetic Technologies Corporation Company Information

11.3.2 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product Offered

11.3.3 Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Applied Genetic Technologies Corporation Main Business Overview

11.3.5 Applied Genetic Technologies Corporation Latest Developments

11.4 Arrowhead Pharmaceuticals, Inc.

11.4.1 Arrowhead Pharmaceuticals, Inc. Company Information

11.4.2 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.4.3 Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Arrowhead Pharmaceuticals, Inc. Main Business Overview

11.4.5 Arrowhead Pharmaceuticals, Inc. Latest Developments

11.5 Carolus Therapeutics, Inc.

11.5.1 Carolus Therapeutics, Inc. Company Information

11.5.2 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.5.3 Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Carolus Therapeutics, Inc. Main Business Overview

11.5.5 Carolus Therapeutics, Inc. Latest Developments

11.6 Cevec Pharmaceuticals GmbH

11.6.1 Cevec Pharmaceuticals GmbH Company Information

11.6.2 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product Offered

11.6.3 Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Cevec Pharmaceuticals GmbH Main Business Overview

11.6.5 Cevec Pharmaceuticals GmbH Latest Developments

11.7 Dicerna Pharmaceuticals, Inc.

11.7.1 Dicerna Pharmaceuticals, Inc. Company Information

11.7.2 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.7.3 Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Dicerna Pharmaceuticals, Inc. Main Business Overview

11.7.5 Dicerna Pharmaceuticals, Inc. Latest Developments

11.8 Digna Biotech, S.L.

11.8.1 Digna Biotech, S.L. Company Information

11.8.2 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.8.3 Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Digna Biotech, S.L. Main Business Overview

11.8.5 Digna Biotech, S.L. Latest Developments

11.9 Editas Medicine, Inc.

11.9.1 Editas Medicine, Inc. Company Information

11.9.2 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.9.3 Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Editas Medicine, Inc. Main Business Overview

11.9.5 Editas Medicine, Inc. Latest Developments

11.10 Grifols, S.A.

11.10.1 Grifols, S.A. Company Information

11.10.2 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.10.3 Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Grifols, S.A. Main Business Overview

11.10.5 Grifols, S.A. Latest Developments

11.11 Inhibrx

11.11.1 Inhibrx Company Information

11.11.2 Inhibrx Alpha- Antitrypsin Deficiency Treatment Product Offered

11.11.3 Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Inhibrx Main Business Overview

11.11.5 Inhibrx Latest Developments

11.12 Intellia Therapeutics, Inc.

11.12.1 Intellia Therapeutics, Inc. Company Information

11.12.2 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.12.3 Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Intellia Therapeutics, Inc. Main Business Overview

11.12.5 Intellia Therapeutics, Inc. Latest Developments

11.13 International Stem Cell Corporation

11.13.1 International Stem Cell Corporation Company Information

11.13.2 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product Offered

11.13.3 International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 International Stem Cell Corporation Main Business Overview

11.13.5 International Stem Cell Corporation Latest Developments

11.14 Ionis Pharmaceuticals, Inc.

11.14.1 Ionis Pharmaceuticals, Inc. Company Information

11.14.2 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.14.3 Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Ionis Pharmaceuticals, Inc. Main Business Overview

11.14.5 Ionis Pharmaceuticals, Inc. Latest Developments

11.15 Kamada Ltd.

11.15.1 Kamada Ltd. Company Information

11.15.2 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.15.3 Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Kamada Ltd. Main Business Overview

11.15.5 Kamada Ltd. Latest Developments

11.16 Polyphor Ltd.

11.16.1 Polyphor Ltd. Company Information

11.16.2 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.16.3 Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Polyphor Ltd. Main Business Overview

11.16.5 Polyphor Ltd. Latest Developments

11.17 ProMetic Life Sciences Inc.

11.17.1 ProMetic Life Sciences Inc. Company Information

11.17.2 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.17.3 ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 ProMetic Life Sciences Inc. Main Business Overview

11.17.5 ProMetic Life Sciences Inc. Latest Developments

11.18 rEVO Biologics, Inc.

11.18.1 rEVO Biologics, Inc. Company Information

11.18.2 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.18.3 rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 rEVO Biologics, Inc. Main Business Overview

11.18.5 rEVO Biologics, Inc. Latest Developments

11.19 Sangamo BioSciences, Inc.

11.19.1 Sangamo BioSciences, Inc. Company Information

11.19.2 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

11.19.3 Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Sangamo BioSciences, Inc. Main Business Overview

11.19.5 Sangamo BioSciences, Inc. Latest Developments

12 Research Findings and Conclusion

Table 1. Alpha- Antitrypsin Deficiency Treatment Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of CT-2009

Table 3. Major Players of POL-6014

Table 4. Major Players of ARO-AAT

Table 5. Major Players of ALNAAT-02

Table 6. Major Players of Others

Table 7. Alpha- Antitrypsin Deficiency Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2022)

Table 10. Alpha- Antitrypsin Deficiency Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2022)

Table 13. Global Alpha- Antitrypsin Deficiency Treatment Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Player (2020-2022)

Table 15. Alpha- Antitrypsin Deficiency Treatment Key Players Head office and Products Offered

Table 16. Alpha- Antitrypsin Deficiency Treatment Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Alpha- Antitrypsin Deficiency Treatment Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Regions (2017-2022)

Table 21. Americas Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Country (2017-2022)

Table 23. Americas Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2022)

Table 25. Americas Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2022)

Table 27. APAC Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Region (2017-2022)

Table 29. APAC Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2022)

Table 31. APAC Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2022)

Table 33. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Country (2017-2022)

Table 35. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2022)

Table 37. Europe Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Alpha- Antitrypsin Deficiency Treatment

Table 46. Key Market Challenges & Risks of Alpha- Antitrypsin Deficiency Treatment

Table 47. Key Industry Trends of Alpha- Antitrypsin Deficiency Treatment

Table 48. Global Alpha- Antitrypsin Deficiency Treatment Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Alpha- Antitrypsin Deficiency Treatment Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Alpha- Antitrypsin Deficiency Treatment Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share Forecast by Application (2023-2028)

Table 54. Adverum Biotechnologies, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 55. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 56. Adverum Biotechnologies, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Adverum Biotechnologies, Inc. Main Business

Table 58. Adverum Biotechnologies, Inc. Latest Developments

Table 59. Alnylam Pharmaceuticals, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 60. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 61. Alnylam Pharmaceuticals, Inc. Main Business

Table 62. Alnylam Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Alnylam Pharmaceuticals, Inc. Latest Developments

Table 64. Applied Genetic Technologies Corporation Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 65. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 66. Applied Genetic Technologies Corporation Main Business

Table 67. Applied Genetic Technologies Corporation Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Applied Genetic Technologies Corporation Latest Developments

Table 69. Arrowhead Pharmaceuticals, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 70. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 71. Arrowhead Pharmaceuticals, Inc. Main Business

Table 72. Arrowhead Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Arrowhead Pharmaceuticals, Inc. Latest Developments

Table 74. Carolus Therapeutics, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 75. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 76. Carolus Therapeutics, Inc. Main Business

Table 77. Carolus Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Carolus Therapeutics, Inc. Latest Developments

Table 79. Cevec Pharmaceuticals GmbH Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 80. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 81. Cevec Pharmaceuticals GmbH Main Business

Table 82. Cevec Pharmaceuticals GmbH Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Cevec Pharmaceuticals GmbH Latest Developments

Table 84. Dicerna Pharmaceuticals, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 85. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 86. Dicerna Pharmaceuticals, Inc. Main Business

Table 87. Dicerna Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Dicerna Pharmaceuticals, Inc. Latest Developments

Table 89. Digna Biotech, S.L. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 90. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 91. Digna Biotech, S.L. Main Business

Table 92. Digna Biotech, S.L. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Digna Biotech, S.L. Latest Developments

Table 94. Editas Medicine, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 95. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 96. Editas Medicine, Inc. Main Business

Table 97. Editas Medicine, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. Editas Medicine, Inc. Latest Developments

Table 99. Grifols, S.A. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 100. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 101. Grifols, S.A. Main Business

Table 102. Grifols, S.A. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Grifols, S.A. Latest Developments

Table 104. Inhibrx Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 105. Inhibrx Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 106. Inhibrx Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Inhibrx Main Business

Table 108. Inhibrx Latest Developments

Table 109. Intellia Therapeutics, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 110. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 111. Intellia Therapeutics, Inc. Main Business

Table 112. Intellia Therapeutics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Intellia Therapeutics, Inc. Latest Developments

Table 114. International Stem Cell Corporation Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 115. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 116. International Stem Cell Corporation Main Business

Table 117. International Stem Cell Corporation Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. International Stem Cell Corporation Latest Developments

Table 119. Ionis Pharmaceuticals, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 120. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 121. Ionis Pharmaceuticals, Inc. Main Business

Table 122. Ionis Pharmaceuticals, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Ionis Pharmaceuticals, Inc. Latest Developments

Table 124. Kamada Ltd. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 125. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 126. Kamada Ltd. Main Business

Table 127. Kamada Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Kamada Ltd. Latest Developments

Table 129. Polyphor Ltd. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 130. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 131. Polyphor Ltd. Main Business

Table 132. Polyphor Ltd. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Polyphor Ltd. Latest Developments

Table 134. ProMetic Life Sciences Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 135. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 136. ProMetic Life Sciences Inc. Main Business

Table 137. ProMetic Life Sciences Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. ProMetic Life Sciences Inc. Latest Developments

Table 139. rEVO Biologics, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 140. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 141. rEVO Biologics, Inc. Main Business

Table 142. rEVO Biologics, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 143. rEVO Biologics, Inc. Latest Developments

Table 144. Sangamo BioSciences, Inc. Details, Company Type, Alpha- Antitrypsin Deficiency Treatment Area Served and Its Competitors

Table 145. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Product Offered

Table 146. Sangamo BioSciences, Inc. Main Business

Table 147. Sangamo BioSciences, Inc. Alpha- Antitrypsin Deficiency Treatment Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 148. Sangamo BioSciences, Inc. Latest Developments

List of Figures

Figure 1. Alpha- Antitrypsin Deficiency Treatment Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Alpha- Antitrypsin Deficiency Treatment Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type in 2021

Figure 7. Alpha- Antitrypsin Deficiency Treatment in Clinic

Figure 8. Global Alpha- Antitrypsin Deficiency Treatment Market: Clinic (2017-2022) & ($ Millions)

Figure 9. Alpha- Antitrypsin Deficiency Treatment in Hospital

Figure 10. Global Alpha- Antitrypsin Deficiency Treatment Market: Hospital (2017-2022) & ($ Millions)

Figure 11. Alpha- Antitrypsin Deficiency Treatment in Others

Figure 12. Global Alpha- Antitrypsin Deficiency Treatment Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2021

Figure 14. Global Alpha- Antitrypsin Deficiency Treatment Revenue Market Share by Player in 2021

Figure 15. Global Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Alpha- Antitrypsin Deficiency Treatment Market Size 2017-2022 ($ Millions)

Figure 17. APAC Alpha- Antitrypsin Deficiency Treatment Market Size 2017-2022 ($ Millions)

Figure 18. Europe Alpha- Antitrypsin Deficiency Treatment Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size 2017-2022 ($ Millions)

Figure 20. Americas Alpha- Antitrypsin Deficiency Treatment Value Market Share by Country in 2021

Figure 21. Americas Alpha- Antitrypsin Deficiency Treatment Consumption Market Share by Type in 2021

Figure 22. Americas Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2021

Figure 23. United States Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Region in 2021

Figure 28. APAC Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2021

Figure 29. China Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Country in 2021

Figure 36. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type in 2021

Figure 37. Europe Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2021

Figure 38. Germany Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size Market Share by Application in 2021

Figure 46. Egypt Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Alpha- Antitrypsin Deficiency Treatment Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 52. APAC Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 53. Europe Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 55. United States Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 56. Canada Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 59. China Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 60. Japan Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 61. Korea Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 63. India Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 64. Australia Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 65. Germany Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 66. France Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 67. UK Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 68. Italy Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 69. Russia Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 70. Spain Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 73. Israel Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Alpha- Antitrypsin Deficiency Treatment Market Size 2023-2028 ($ Millions)